Kenya receives 200,000 Sinopharm Covid-19 jabs from China

Health PS Susan Mochache receives 200,000 Sinopharm Covid-19 jabs from Zhang Yijun, Minister Counsellor of the Chinese Embassy in Kenya, at JKIA on September 18, 2021/ MOH

Kenya continues vaccines from different states, the recent donation being 200,000 Sinopharm Covid-19 jabs from China, which arrived in the country on Saturday.

This is the first batch of the Chinese vaccine in Kenya and is the fifth type of the jab  that will be in deployed in the country alongside Astrazeneca, Moderna, Johnson and Johnson and Pfizer.

“The vaccines we are receiving today are testament to the cordial relations that exist between our two countries that extend beyond health care to include trade and other sectors of development,” Health PS Susan Mochache said at JKIA, where she received the consignment.

Mochache added that China has distinguished herself in quality products and the vaccines Kenya received are of high quality and have also been approved by the World Health Organization.

“I am sure there are a lot of questions regarding this vaccine. Let me state from the onset that the Sinopharm vaccine is a two-dose vaccine with a 28-day gap between the first and second dose. In addition, the storage condition is 2 to 8 degrees”.

“This will therefore fit in very well in the current cold chain storage capacity we have in our vaccine stores,” the PS said as she thanked the government of China represented by Zhang Yijun, Minister Counsellor of the Chinese Embassy in Kenya. for supporting the vaccination drive, which seeks to vaccinate 10 million people by December.

Mochache noted that although the consignment has been delivered courtesy of our strong bilateral relations with China, Sinopharm is also available through Kenya’s engagement with the COVAX mechanism, and the country shall be getting more supplies through the platform in the near future when available.

The Chinese donation comes a day after the US gave 795,600 doses of Pfizer vaccine.

Kenya receives 795,600 doses of Pfizer vaccine from US

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

The Brief will use the information you provide on this form to be in touch with you and to provide updates and marketing.